Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, September 21, 2026

Construction and multi-center validation of a model based on blending ensemble learning for predicting stroke-associated pneumonia following acute ischemic stroke

 

Predictions are useless!  Solve the correct problem!  You've known of the need to prevent pneumonia for years! I'd have you all fired for incompetence!

Construction and multi-center validation of a model based on blending ensemble learning for predicting stroke-associated pneumonia following acute ischemic stroke


  • 1. First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China

  • 2. National Clinical Research Center for Chinese Medicine, Tianjin, China

Abstract


Background: 


Stroke-associated pneumonia (SAP) is a common and serious infectious complication following acute ischemic stroke (AIS), leading to worsened clinical outcomes. We aimed to develop and validate a novel predictive model based on Blending Ensemble Learning, to enable early, precise screening and individualized risk stratification for SAP.


Methods: 


In this multi-center study, a derivation cohort was initially established using 1,123 patients admitted between 2022 and 2024. Subsequently, 199 patients were prospectively enrolled in early 2025 as a temporal validation set, and 287 patients were extracted from a regional health big data platform (covering 12 hospitals) to serve as an external validation set. High-value clinical and biomarker features were identified via least absolute shrinkage and selection operator (LASSO) regression. To overcome the limitations of single classifiers, a Blending Ensemble Learning strategy was adopted to construct the final predictive model. The model underwent comprehensive evaluation for discrimination, calibration, and clinical utility, and was benchmarked against single random forest (RF) and extreme gradient boosting (XGBoost) models.


Results: 


Seventeen predictors were identified, including systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), the National Institutes of Health Stroke Scale (NIHSS), and D-dimer. The Blending ensemble model demonstrated superior discrimination in the validation cohort, achieving an Area Under the Receiver Operating Characteristic Curve (AUC) of 0.898 (95% CI: 0.845–0.951), which significantly outperformed the optimal single model. Furthermore, SHapley Additive exPlanations (SHAP) analysis highlighted hyperinflammation, immunothrombosis, and nutritional depletion as pivotal mechanisms driving SAP pathogenesis.


Conclusion: 


The proposed Blending ensemble model exhibits excellent generalizability and high sensitivity. The accompanying web-based tool provides robust decision support for identifying high-risk patients and implementing early precision interventions.

No comments:

Post a Comment